WO2018050955A1 - Insulin pen - Google Patents
Insulin pen Download PDFInfo
- Publication number
- WO2018050955A1 WO2018050955A1 PCT/FI2017/000014 FI2017000014W WO2018050955A1 WO 2018050955 A1 WO2018050955 A1 WO 2018050955A1 FI 2017000014 W FI2017000014 W FI 2017000014W WO 2018050955 A1 WO2018050955 A1 WO 2018050955A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- insulin
- pen
- insulin pen
- reservoir
- propellant gas
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M5/2046—Media being expelled from injector by gas generation, e.g. explosive charge
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M5/2053—Media being expelled from injector by pressurised fluid or vacuum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3148—Means for causing or aiding aspiration or plunger retraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
- A61M5/31545—Setting modes for dosing
- A61M5/31548—Mechanically operated dose setting member
- A61M5/3155—Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
- A61M5/2455—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic with sealing means to be broken or opened
- A61M5/2466—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic with sealing means to be broken or opened by piercing without internal pressure increase
- A61M2005/247—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic with sealing means to be broken or opened by piercing without internal pressure increase with fixed or steady piercing means, e.g. piercing under movement of ampoule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3125—Details specific display means, e.g. to indicate dose setting
- A61M2005/3126—Specific display means related to dosing
Definitions
- This invention relates to an insulin pen, comprising an insulin reservoir and an injection needle, and at the opposite end of the insulin pen a press-button, by means of which an insulin dose is injected in the patient's body.
- a pharmaceutical was injected in the body of an individual by human power by means of a mechanically operating pen device, such as for instance NovoRapid, FlexPen, Lantus Solostar, and other models.
- the purpose of the invention is to eliminate the disadvantages mentioned above.
- the insulin pen in accordance with the invention is characterised by the fact that the insulin pen comprises a pressure reservoir filled with propellant gas, the pressure reservoir being opened by pressing a press-button so that the propellant gas presses the insulin dose through the injection needle into the patient's body.
- the injection moment always lasts 10 seconds, during which the patient receives a maximally uniform insulin dose regardless of the number of units to be injected. This ensures a well balanced treatment of the patient.
- the prefilled pressure cartridge of the insulin pen is emptied to 100%.
- Prefilled insulin pens known per se such as e.g. NovoRapid, FlexPen and Lantus Solostar will contain a remainder of drug liquid of 10 units, even if the pen is in zero position. The cut in insulin will thus be considerable.
- the pen is safe and easy to use.
- the insulin pen emits distinct and audible clicks at regular intervals. At the moment of injection, the pen emits a weak sound over the entire injection duration for the user to internalise the injection time.
- This economisation corresponds to one prefilled insulin pen.
- On a global scale this is a remarkable gain.
- the worldwide number of users exceeds 300 millions.
- Anybody can conclude the amount of insulin and the number of insulin pens economised with the insulin pen in accordance with the invention.
- Persons with a physical disability learn how to use the insulin pen exceptionally well. It is easy for a blind person to internalise the injection process.
- the pen is safe for injections in persons suffering from other medical conditions and for the elderly. No physical force is required for carrying out the injection under the skin into the body.
- a pressure-operated prefilled insulin pen can also be converted for use with a removable cartridge.
- the pressure chamber can be converted into a pressure cylinder.
- the insulin pen comprises an insulin reservoir 1 and an injection needle 2, and at the opposite end of the insulin pen, a press-button 3, by means of which an insulin dose is injected into the patient's body.
- the insulin pen comprises a pressure reservoir 4 filled with propellant gas, and the pressure reservoir can be opened with the press- button 3 so that the propellant gas presses an insulin dose through the injection needle 2 into the patient's body.
- a piston 6 pressed by propellant gas is provided between the pressure reservoir 4 and the insulin reservoir and moves within the body 5 of the insulin pen, thus pressing the total insulin dose into the patient's body.
- a control knob 7 for the number of insulin units is located in connection with the press-button 3 for control of the insulin dosage.
- a reading of the number of units to be controlled and the one desired is shown in the dose window 8.
- a pressure nozzle 9 is provided between the pressure reservoir 4 and the piston 6 for choking the amount of propellant gas so as to set the specific injection duration, preferably 10 seconds.
- the present embodiment comprises a cylindrical insulin reservoir within the body, which, however, can be replaced with a removable cartridge. If necessary, a refilling valve 10 may be provided in the upper part of the pressure reservoir 4 for cases when the user refills the pressure reservoir personally.
- the injection needle 2 is supported with a rubber stopper 11 and protected with a pen casing 12.
- the length L of the injection needle may be e.g. app. 140 mm and the diameter D app. 15 mm.
- the dimensions of a potential cartridge used in the injection needle are; length 67 mm and diameter 11 mm.
- a dosage control system operating with a plastic cogwheel known per se is located between the control knob and the pressure reservoir for controlling the dosage (not shown in the figure).
Abstract
The invention relates to an insulin pen comprising an insulin reservoir (1) and an injection needle (2), and at the opposite end of the insulin pen, a press-button (3), by means of which an insulin dose is injected into the patient's body. The insulin pen comprises a pressure reservoir (4) which is filled with propellant gas and can be opened by pressing the press-button so that the propellant gas presses an insulin dose through the injection needle (2) into the patient's body.
Description
Insulin pen
This invention relates to an insulin pen, comprising an insulin reservoir and an injection needle, and at the opposite end of the insulin pen a press-button, by means of which an insulin dose is injected in the patient's body.
Previously a pharmaceutical was injected in the body of an individual by human power by means of a mechanically operating pen device, such as for instance NovoRapid, FlexPen, Lantus Solostar, and other models.
Injections are difficult to carry out regarding patients with physical disabilities and elderly people. It has also been noted that the waste percentage of prefilled insulin pens is app. 10 units.
The purpose of the invention is to eliminate the disadvantages mentioned above. The insulin pen in accordance with the invention is characterised by the fact that the insulin pen comprises a pressure reservoir filled with propellant gas, the pressure reservoir being opened by pressing a press-button so that the propellant gas presses the insulin dose through the injection needle into the patient's body.
Various embodiments of the invention are described in the dependent claims of the set of claims.
The injection moment always lasts 10 seconds, during which the patient receives a maximally uniform insulin dose regardless of the number of units to be injected. This ensures a well balanced treatment of the patient. The prefilled pressure cartridge of the insulin pen is emptied to 100%. Prefilled insulin pens known per se, such as e.g. NovoRapid, FlexPen and Lantus Solostar will contain a remainder of drug liquid of 10 units, even if the pen is in zero position. The cut in insulin will thus be considerable. The pen is safe and easy to use. The insulin pen emits distinct and audible clicks at regular intervals. At the moment of injection, the pen emits a weak sound over the entire injection duration for the user to internalise the injection time.
Assuming a consumption of 30 prefilled insulin pens witch each of them leaving 10 units in the cartridge, the insulin pen in accordance with the invention achieves a reduction of 30x10=300 units, equalling 3 ml. This economisation corresponds to
one prefilled insulin pen. On a global scale this is a remarkable gain. The worldwide number of users exceeds 300 millions. Anybody can conclude the amount of insulin and the number of insulin pens economised with the insulin pen in accordance with the invention. Persons with a physical disability learn how to use the insulin pen exceptionally well. It is easy for a blind person to internalise the injection process. The pen is safe for injections in persons suffering from other medical conditions and for the elderly. No physical force is required for carrying out the injection under the skin into the body. A pressure-operated prefilled insulin pen can also be converted for use with a removable cartridge. The pressure chamber can be converted into a pressure cylinder. Although this invention relates to an insulin pen, the pen in accordance with the invention is evidently appropriate for other pharmaceuticals to be injected as well. The invention is explained below by means of an example and with reference to the accompanying drawing, which illustrates the insulin pen in partial section.
The insulin pen comprises an insulin reservoir 1 and an injection needle 2, and at the opposite end of the insulin pen, a press-button 3, by means of which an insulin dose is injected into the patient's body. The insulin pen comprises a pressure reservoir 4 filled with propellant gas, and the pressure reservoir can be opened with the press- button 3 so that the propellant gas presses an insulin dose through the injection needle 2 into the patient's body. A piston 6 pressed by propellant gas is provided between the pressure reservoir 4 and the insulin reservoir and moves within the body 5 of the insulin pen, thus pressing the total insulin dose into the patient's body.
If a smaller dose than the entire dose provided in the pen is desired, a control knob 7 for the number of insulin units is located in connection with the press-button 3 for control of the insulin dosage. A reading of the number of units to be controlled and the one desired is shown in the dose window 8. A pressure nozzle 9 is provided between the pressure reservoir 4 and the piston 6 for choking the amount of propellant gas so as to set the specific injection duration, preferably 10 seconds. The present embodiment comprises a cylindrical insulin reservoir within the body, which, however, can be replaced with a removable cartridge. If necessary, a refilling valve 10 may be provided in the upper part of the pressure reservoir 4 for cases when the user refills the pressure reservoir personally. The injection needle 2 is supported with a rubber stopper 11 and protected with a pen casing 12. The length L of the injection needle may be e.g. app. 140 mm and the diameter D app. 15 mm. The dimensions of a potential cartridge used in the injection needle are; length 67 mm and diameter 11
mm. A dosage control system operating with a plastic cogwheel known per se is located between the control knob and the pressure reservoir for controlling the dosage (not shown in the figure).
Claims
1. an insulin pen comprising an insulin reservoir (1) and an injection needle (2), and at the opposite end of the insulin pen, a press-button (3), by means of which an insulin dose is injected into the patient's body, characterised in that the insulin pen comprises a pressure reservoir (4) which is filled with propellant gas and can be opened by pressing the press-button so that the propellant gas presses the insulin dose through the injection needle (2) into the patient's body.
2. An insulin pen as defined in claim 1 , characterised in that a piston (6) pressed by propellant gas and moving within the body (5) of the insulin pen is provided between the pressure reservoir (4) and the insulin reservoir (1), the piston pressing the entire insulin dose into the patient's body. .
3. An insulin pen as defined in claim 1 or 2, characterised in that a control knob (7) of the number of insulin units is provided in connection with the press-button (3) for controlling the insulin dosage.
4. An insulin pen as defined in claim 1 , 2 or 3, characterised in that a pressure nozzle (9) is provided between the pressure reservoir (4) and the piston (6) for choking the amount of propellant gas so as to set the specific injection duration, preferably 10 seconds.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20160228 | 2016-09-13 | ||
FI20160228 | 2016-09-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2018050955A1 true WO2018050955A1 (en) | 2018-03-22 |
WO2018050955A8 WO2018050955A8 (en) | 2018-10-04 |
Family
ID=61619065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FI2017/000014 WO2018050955A1 (en) | 2016-09-13 | 2017-09-12 | Insulin pen |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2018050955A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020012178A1 (en) * | 2018-07-10 | 2020-01-16 | Pacifi Limited | Method and apparatus |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3977401A (en) * | 1975-03-25 | 1976-08-31 | William Floyd Pike | Injection apparatus |
US6045534A (en) * | 1997-10-27 | 2000-04-04 | Sarcos, Inc. | Disposable fluid injection module |
US20110092906A1 (en) * | 2008-06-19 | 2011-04-21 | Arzeneimittel Gmbh Apotheker Vetter & Co. Ravensburg | Device with at least one chamber for receiving a medicament or a sample volume |
-
2017
- 2017-09-12 WO PCT/FI2017/000014 patent/WO2018050955A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3977401A (en) * | 1975-03-25 | 1976-08-31 | William Floyd Pike | Injection apparatus |
US6045534A (en) * | 1997-10-27 | 2000-04-04 | Sarcos, Inc. | Disposable fluid injection module |
US20110092906A1 (en) * | 2008-06-19 | 2011-04-21 | Arzeneimittel Gmbh Apotheker Vetter & Co. Ravensburg | Device with at least one chamber for receiving a medicament or a sample volume |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020012178A1 (en) * | 2018-07-10 | 2020-01-16 | Pacifi Limited | Method and apparatus |
Also Published As
Publication number | Publication date |
---|---|
WO2018050955A8 (en) | 2018-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5030942B2 (en) | Injection device with secondary reservoir | |
US20170340811A1 (en) | Mechanical injection pump and method of use | |
RU2491965C2 (en) | Injection device with means of electronic control | |
US4013074A (en) | Implantable medication-dispensing device | |
RU2608622C2 (en) | Manual device for basal bolus drug delivery | |
ES488986A0 (en) | AN IMPLASTABLE INFUSION DEVICE FOR ADMINISTERING PRECISION REGULATED DRUG DOSE UNDER EXTERNAL CONTROL. | |
WO2009004627A3 (en) | A device for drug delivery | |
DE602005014982D1 (en) | DEVICE FOR THE THERAPEUTIC DELIVERY OF A MEDICAMENT | |
JP6336401B2 (en) | Dose end indicator | |
CN113301933A (en) | Nasal cavity medicine delivery device | |
JP6032892B2 (en) | Cartridge stopper for intradermal administration system | |
WO2018050955A1 (en) | Insulin pen | |
US9533098B2 (en) | Injection device for the needle-free injection of a medium | |
US20180369480A1 (en) | Injection device for injecting dosed amounts of a liquid therapeutic agent | |
DE102016120926A1 (en) | Injection device for injecting metered quantities of a liquid therapeutic agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17850346 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 17850346 Country of ref document: EP Kind code of ref document: A1 |